Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Disc Medicine, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −7 vs. Q2 2022
- Shares held
- 26.7M
- +829.3K (+3.2%) vs. Q2 2022
- Total value
- $43.9M
- +$44.0K (+0.1%) vs. Q2 2022
- New holders
- 6
- 9 more added
- Sold out
- 13
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 246 | $0 | 0.00% | +6+2.5% | Added |
| Wells Fargo & Company | 146 | $0 | 0.00% | −2−1.4% | Reduced |
| TCI Wealth Advisors, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 59 | $0 | 0.00% | −47−44.3% | Reduced |
| Royal Bank of Canada | 131 | $0 | 0.00% | +131 | New |
| Tower Research Capital LLC (TRC) | 508 | $1.00K | 0.00% | −7,329−93.5% | Reduced |
| Ulland Investment Advisors, LLC | 348 | $1.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 6,455 | $11.0K | 0.00% | +6,455 | New |
| Running Point Capital Advisors, LLC | 10,000 | $16.0K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,008 | $18.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 12,511 | $20.0K | 0.00% | +12,012+2,407.2% | Added |
| Wolverine Trading, LLC | 16,030 | $24.0K | 0.00% | +16,030 | New |
| Qube Research & Technologies Ltd | 16,482 | $27.0K | 0.00% | −2,128−11.4% | Reduced |
| Goldman Sachs Group Inc | 19,485 | $32.0K | 0.00% | −17,150−46.8% | Reduced |
| Morgan Stanley | 27,351 | $45.0K | 0.00% | −3,634−11.7% | Reduced |
| Fiduciary Trust Co | 40,510 | $66.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 48,645 | $80.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 50,871 | $83.0K | 0.00% | −222−0.4% | Reduced |
| ExodusPoint Capital Management, LP | 51,779 | $85.0K | 0.00% | +51,779 | New |
| UBS Group AG | 61,900 | $102.0K | 0.00% | −76,570−55.3% | Reduced |
| MYDA Advisors LLC | 63,000 | $103.0K | 0.06% | +43,000+215.0% | Added |
| Bridgeway Capital Management, LLC | 75,000 | $123.0K | 0.00% | +27,500+57.9% | Added |
| Assenagon Asset Management S.A. | 82,171 | $135.0K | 0.00% | +66,467+423.2% | Added |
| Ergoteles LLC | 92,200 | $151.0K | 0.01% | −13,900−13.1% | Reduced |
| State Street Corp | 101,899 | $167.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 137,221 | $225.0K | 0.00% | +43,600+46.6% | Added |
| Renaissance Technologies LLC | 179,858 | $295.0K | 0.00% | −100,742−35.9% | Reduced |
| K2 Principal Fund, L.P. | 193,124 | $317.0K | 0.08% | −99,621−34.0% | Reduced |
| BlackRock Inc. | 200,554 | $330.0K | 0.00% | −13,471−6.3% | Reduced |
| Harvard Management Co Inc | 250,000 | $410.0K | 0.05% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 257,672 | $423.0K | 0.04% | +257,672 | New |
| Geode Capital Management, LLC | 272,271 | $446.0K | 0.00% | +1,156+0.4% | Added |
| Millennium Management LLC | 342,532 | $562.0K | 0.00% | −419,631−55.1% | Reduced |
| FMR LLC | 394,578 | $647.0K | 0.00% | −1,106−0.3% | Reduced |
| 5AM Venture Management, LLC | 524,500 | $860.0K | 0.16% | +524,500 | New |
| Vanguard Group Inc | 557,999 | $915.0K | 0.00% | −138,265−19.9% | Reduced |
| Citadel Advisors LLC | 579,914 | $951.0K | 0.00% | +12,946+2.3% | Added |
| Boxer Capital, LLC | 1,300,000 | $2.13M | 0.12% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,372,267 | $3.89M | 0.16% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 2,435,125 | $3.99M | 3.07% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $3.99M | 11.99% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,447,477 | $4.01M | 0.01% | +1,564,865+177.3% | Added |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $8.62M | 0.95% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,826,223 | $9.55M | 0.19% | −10.0% | Reduced |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −443,096−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −150,393−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −87,648−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −61,701−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −42,297−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −31,099−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −29,002−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −27,563−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,530−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −11,369−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −201−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |